Direct and extraction-free detection of viral human and veterirnay pathogens seeking validation parters
A UK company has developed a patent pending instrument and reagents for direct detection of viral pathogens. Extraction-free, they are suitable for a rapid rollout allowing for much better preparedness for future pandemics. Early production units will come in Q2 2026. They seek health industry partners for maturing and validating a series of tests under technical or research cooperation projects.